- Companies
- MediTrust Health
MediTrust Health Revenue, Valuation, Funding & Investors
MediTrust Health is valued at $1.4B as of August 2021, a 9.3x multiple on its last reported $154M revenue.
Last MediTrust Health valuation
$1.4B
Series C · Aug 2021
Last MediTrust Health funding round
$308M
Series C · Aug 2021
MediTrust Health revenue
$154M
Series C · Aug 2021
Key investors in MediTrust Health
Boyu Capital
Janchor Partners
MediTrust Health Overview
About MediTrust Health
MediTrust Health is a Shanghai-based healthcare platform that connects pharmaceutical companies, insurers, hospitals, and patients across China. Launched in 2015, it distributes diverse health insurance products alongside medical benefits and services like telemedicine and drug delivery. MediTrust integrates high-quality resources to offer families economical, personalized healthcare protection and hospital access. The platform forms a closed-loop ecosystem among payers, suppliers, and end-users, with operations spanning major Chinese cities and partnerships with leading insurers.
Founded
2017
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Commission, Subscription
Revenue
$154M (Aug 2021)
Valuation
$1.4B (Aug 2021)
MediTrust Health Valuation
MediTrust Health is currently valued at $1.4B, based on its Series C in August 2021.
The $308M round was led by Boyu Capital and Janchor Partners.
MediTrust Health valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Aug 2021 | Series C | $1.4B | 9.3x |
MediTrust Health Revenue
MediTrust Health's latest recorded revenue is $154M, as of its Series C in August 2021. At a $1.4B valuation, that implies a 9.3x revenue multiple.
MediTrust Health revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Aug 2021 | $154M | $1.4B | 9.3x | Series C |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
MediTrust Health Funding History
MediTrust Health has raised a total of $308M across 1 funding round.
MediTrust Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Aug 2021 | Series C | Boyu Capital (lead); Janchor Partners (lead) | $308M | $1.4B | MediTrust Health is a China-based online healthcare payment and pharmacy platform that provides digital solutions for purchasing prescription medicines, accessing insurance products, and settling medical bills. The company operates multiple service lines including Care2Pay, a healthcare benefit platform that collaborates with over 50 pharmaceutical companies and insurance providers and more than 2,000 pharmacies across 400+ cities; Kangfu Zhibao, a health insurance aggregator platform offering personalized policies and payment settlement options; and iCare Internet Hospital providing access to new drugs and novel therapies. In August 2021, MediTrust Health raised $308 million in Series C financing jointly led by Boyu Capital and Janchor Partners, with participation from Lilly Asia Ventures, Lake Bleu Capital, Bank of China Group Investment, AIHC Capital, China Everbright, New Alliance Capital, B Capital Group, CICC Capital, and follow-on investment from Shanghai Biopharmaceutical Investment Fund, Sinovation Ventures, China Renaissance, and Marathon Venture Partners. The company expected annual revenue of more than $154.2 million for 2021. By the first half of 2021, Care2Pay had helped patients save approximately 300 million yuan ($46.2 million) in healthcare expenses, and MediTrust's services supported enrollment of 7.39 million people—over one-third of eligible citizens in Shanghai—in the municipal health insurance expansion program known as Huhuibao. The digital health market was projected to reach $426.8 billion by 2027 with a compound annual growth rate of 17.4%, driven by increased demand for healthcare digitization and advancements in virtual care infrastructure. |
Who has invested in MediTrust Health?
2 investors have backed MediTrust Health across its funding rounds, including Boyu Capital and Janchor Partners.
Lead investors include Boyu Capital and Janchor Partners.
MediTrust Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 2 MediTrust Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialMediTrust Health Competitors
MediTrust Health competitors include listed companies like Value HR and Indegene, and private ones like Collective Health, Strive Health, Rightway and UpStream Care.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.5B | - | ||
| Private | - | - | $1.8B | - | ||
| Private | - | - | $1.1B | - | ||
| Private | - | - | $1B | - | ||
| Publicly listed | $65M | $9M | $270M | 4.1x | ||
| Publicly listed | $366M | $68M | $1.5B | 3.3x |
MediTrust Health Public Comps
MediTrust Health is still privately-owned, but its public comps include Indegene, Omnicell, EverCommerce, U.S. Physical Therapy, GoodRx, PHC Holdings, Alignment Healthcare, Qingdao Baheal Medical, Vitec Software and iFLYHealth.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $366M | $68M | 3.7x | 3.3x | 19.9x | 18.2x | |||
| $1.2B | $92M | 1.2x | 1.1x | 15.0x | 8.1x | |||
| $589M | $128M | 3.0x | 2.9x | 13.7x | 9.5x | |||
| $781M | $110M | 2.5x | 2.3x | 17.5x | 18.9x | |||
| $797M | $173M | 1.8x | 1.8x | 8.1x | 5.5x | |||
| $2.3B | $320M | 1.0x | 1.0x | 7.2x | 6.5x | |||
| $3.9B | $45M | 0.4x | 0.3x | 31.6x | 10.0x | |||
| $1.1B | $139M | 1.9x | 1.9x | 15.1x | 16.8x | |||
This data is available for Pro users. Sign up to see all MediTrust Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about MediTrust Health
| When was MediTrust Health founded? | MediTrust Health was founded in 2017. |
| Where is MediTrust Health headquartered? | MediTrust Health is headquartered in Shanghai, China. |
| Is MediTrust Health publicly listed? | No, MediTrust Health is a private, VC-backed company. |
| What is MediTrust Health's valuation? | MediTrust Health was last valued at $1.4B in its Series C in August 2021. |
| How much funding has MediTrust Health raised? | MediTrust Health has raised $308M across 1 funding round. |
| What was MediTrust Health's last funding round? | MediTrust Health's last funding round was a $308M Series C in August 2021, led by Boyu Capital and Janchor Partners. |
| Who are MediTrust Health's investors? | MediTrust Health's investors include Boyu Capital and Janchor Partners. |
| What is MediTrust Health's revenue? | MediTrust Health's latest recorded revenue is $154M (August 2021). |
| What is MediTrust Health's revenue multiple? | MediTrust Health's latest valuation implies a 9.3x revenue multiple ($1.4B valuation on $154M of revenue). |
| Which companies are comparable to MediTrust Health? | Companies comparable to MediTrust Health include Collective Health, Strive Health, Rightway, UpStream Care, Value HR and Indegene. |
See companies similar to MediTrust Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




